Blog Archives - Hemolens

March 8, 2024

Exploring Sex Differences in Heart Health: Understanding Coronary Artery Plaque Burden

As we approach International Women’s Day, it’s essential to shed light on the unique aspects of women’s health, including...

March 7, 2023

Hemolens Diagnostics in the final of the Start-Up-Med competition

The Start-Up-Med competition is a prestigious initiative organized by PTWP Group (Polish Association for Entrepreneurship Support), publisher of, among...

March 1, 2023

The Bronze Medal for Identities at the International Creative Media Awards goes to Hemolens Diagnostics

Rebranding is a process aimed at changing one or more elements of a brand’s image communication. This includes changes...

February 24, 2023

HEMOFLOW cloud platform for non-invasive hemodynamic diagnositics

The research project ‘HEMOFLOW cloud platform for non-invasive hemodynamic diagnostics’, No. POIR.01.01.01-00-0393/19, aims to assess the diagnostic value of...

November 21, 2022

Panaxea presented the results of a study evaluating the functionality of FFR-CT versus standard diagnostics in patients with stable (continuous) chest pain in the Netherlands

On 10 November at the ISPOR 2022 Europe conference, independent research company Panaxea presented the results of a study...

October 11, 2022

Hemolens Diagnostics on the 14th edition of the “New developments in interventional cardiology”

On October 7-8th, 2022 the 14th edition of the “New developments in interventional cardiology” congress took place in Augustow (Poland),...